Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Under a physician's care for CKD for \> 2 months and are not expected to begin dialysis for 4 months~* Screening estimated GFR of 15-59 mL/1.73 m2~* Serum phosphorus \>= 4.7 mg/d following washout~Exclusion Criteria:~* Requiring treatment with cinacalcet HCI or compounds containing phosphate, aluminum, calcium or magnesium~* Rapidly progressing glomerulonephritis~* Cirrhosis or other clinically significant liver diseases~* Past or present uncontrolled peptic ulcer, Crohn's disease, malignancy or recent GI bleed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).